PET and MRI of the thalamus in never-medicated patients with schizophrenia

American Journal of Psychiatry

Volumn 153, Issue 2, 1996, Pages 191-199

  Buchsbaum, Monte S ^a   Someya, Toshiyuki ^b   Teng, Chuck Ying ^b   Abel, Lennart ^b   Chin, Samuel ^b   Najafi, Ahmad ^b   Haier, Richard J ^b   Wu, Joseph ^b   Bunney Jr , William E ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN BLOOD FLOW; CELL DENSITY; CLINICAL ARTICLE; FEMALE; GLUCOSE METABOLISM; HUMAN; MALE; METABOLIC RATE; NERVE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; THALAMUS;

EID: 0030053697     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.153.2.191     Document Type: Article

References (47)

1. Buchsbaum MS: The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophr Bull 1990; 16:377-387
2. Andreasen NC, Rezai K, Alliger R, Swayze VW II, Flaum M, Kirchner P, Cohen G, O'Leary DS: Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia: assessment with Xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 1992; 49:943-958
3. Stuss DT, Benson DF: The Frontal Lobes. New York, Raven Press, 1986
4. Nuechterlein KH, Buchsbaum MS, Dawson ME: Neuropsychological vulnerability to schizophrenia, in The Neuropsychology of Schizophrenia. Edited by Davids A, Cutting J. London, Lawrence Erlbaum Associates, 1994, pp 53-73
5. Crosson B, Hughes CW: Role of the thalamus in language: is it related to thought disorder? Schizophr Bull 1987; 13:605-621
6. Bunney B, Bunney WE Jr, Carlsson A: Schizophrenia and glutamate, in Psychopharmacology: The Fourth Generation of Progress: An Official Publication of the American College of Neuropsychopharmacology. Edited by Bloom FE, Kupfer DJ. New York, Raven Press, 1995, pp 1205-1214
7. Carlsson M, Carlsson A: Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophr Bull 1990; 16:425-432
8. Andreasen NC, Arndt S, Swayze V II, Cizadlo T, Flaum M, O'Leary D, Ehrhardt JC, Yuh WTC: Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 1994; 266:294-298
9. Resnick SM, Gur RE, Alavi A, Gur RC, Reivich M: Positron emission tomography and subcortical glucose metabolism in schizophrenia. Psychiatry Res 1988; 24:1-11
10. Wiesel FA, Blomqvist G, Greitz T, Nyman H, Schalling D, Stone-Elander S, Widen L, Wik G: Regional brain glucose metabolism in neuroleptic free schizophrenic patients in an acute phase of the disease, in Biological Psychiatry 1985: Proceedings of the IVth World Congress of Biological Psychiatry. Edited by Shagass C, Josiassen RC, Bridger WH, Weiss KJ, Stoff D, Simpson GM. New York, Elsevier, 1986, pp 392-394
11. Tamminga CA, Thaker GK, Buchanan R, Kilpatrick B, Alphs LD, Chase TN, Carpenter WT: Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Arch Gen Psychiatry 1992; 49:522-530
12. Buchsbaum MS, Wu JC, DeLisi LE, Holcomb HH, Hazlett E, Cooper-Langston K, Kessler R: Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients. Biol Psychiatry 1987; 22:479-494
13. Wik G, Wiesel FA, Sjögren I, Blomqvist G, Greitz T, Stone-Elander S: Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography. Psychopharmacology (Berl) 1989; 97:309-318
14. Szechtman HJ, Nahmias C, Garnett ES, Firnau G, Brown GM, Kaplan RD, Cleghorn JM: Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Arch Gen Psychiatry 1988; 45:523-532
15. Siegel BV Jr, Buchsbaum MS, Bunney WE Jr, Gottschalk LA, Haier RJ, Lohr JB, Lottenberg S, Najafi A, Nuechterlein KH, Potkin SG, Wu JC: Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. Am J Psychiatry 1993; 150:1325-1336
16. Kling AS, Metter EJ, Riege WH, Kuhl DE: Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression. Am J Psychiatry 1986; 143:175-180
17. Wiesel FA, Wik G, Sjögren S, Blomqvist G, Greitz T, Stone-Elander S: Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates. Acta Psychiatr Scand 1987; 76:628-641
18. Chakos MH, Lieberman JA, Bilder RM, Borenstein M, Lerner G: Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 1994; 151: 1430-1436
19. LaBerge D, Buchsbaum MS: PET measurements of pulvinar activity during an attention task. J Neurosci 1990; 10:613-619
20. Shapiro RM: Regional neuropathology in schizophrenia. Schizophr Res 1993; 10:187-239
21. Pakkenberg B: Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 1990; 47:1023-1028
22. Wing JK, Cooper JE, Sartorius N: The Measurement and Classification of Psychiatric Symptoms: An Instructional Manual for the PSE and CATEGO Programs. New York, Cambridge University Press, 1974
23. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10:799-812
24. Lukoff D, Liberman RP, Nuechterlein KH: Symptom monitoring in the rehabilitation of schizophrenic patients. Schizophr Bull 1986; 12:578-602
25. Cornblait BA, Risch NJ, Faris G, Friedman D, Erlenmeyer-Kimling L: The Continuous Performance Test, Identical Pairs Version (CPT-IP), 1: new findings about sustained attention in normal families. Psychiatry Res 1988; 26:223-238
26. Cornblatt BA, Lenzenweger MF, Erlenmeyer-Kimling L: The Continuous Performance Test, Identical Pairs Version, II: contrasting attentional profiles in schizophrenic and depressed patients. Psychiatry Res 1989; 29:65-85
27. Nuechterlein KH, Parasuraman R, Jiang Q: Visual sustained attention: image degradation produces rapid decrement over time. Science 1983; 220:327-329
28. 18F]-fluoro-2-deoxy-D-glucose using polyether supported nucleophilic substitution. J Nucl Med 1986; 27:235-238
29. Buchsbaum MS, Nuechterlein KH, Haier RJ, Wu J, Sicotte N, Hazlett E, Asarnow R, Potkin S, Guich S: Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography. Br J Psychiatry 1990; 156:216-227
30. Buchsbaum MS, Potkin SG, Marshall JF, Lottenberg S, Teng C, Heh CW, Tafalla R, Reynolds C, Abel L, Plon L, Bunney WE: Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia. Neuropsychopharmacology 1992; 6:155-163
31. Matsui T, Hirano A: An Atlas of the Human Brain for Computerized Tomography. Tokyo, Igaku-Shoin, 1978
32. Gonzales RC, Wintz P: Digital Image Processing. Boston, Addison-Wesley, 1987
33. Hirai T, Jones EG: Distribution of tachykinin- and enkephalin-immunoreactive fibers in the human thalamus. Brain Res Rev 1989; 14:35-52
34. Van Buren JM, Borke RC: Variations and Connections of the Human Thalamus. New York, Springer-Verlag, 1972
35. Arndt S, Cohen G, Alliger RJ, Swayze VW II, Andreasen NC: Problems with ratio and proportion measures of imaged cerebral structures. Psychiatry Res Neuroimaging 1991; 40:79-89
36. Dixon WJ: BMDP Statistical Software. Berkeley, University of California Press, 1981, pp 388-412
37. Andreasen NC, Ehrhardt JC, Swayze VW II, Alliger RJ, Yuh WT, Cohen G, Ziebell S: Magnetic resonance imaging of the brain in schizophrenia: the pathophysiologic significance of structural abnormalities. Arch Gen Psychiatry 1990; 47:35-44
38. Jernigan TL, Zisook S, Heaton RK, Moranville JT, Hesselink JR, Braff DL: Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenics. Arch Gen Psychiatry 1991; 48:881-890
39. Baron JC, D'Antona R, Pantano P, Serdaru M, Samson Y, Bousser MG: Effects of thalamic stroke on energy metabolism of the cerebral cortex. Brain 1986; 109:1243-1259
40. Hennerici U, Halsband T, Kuwert H, Steinmetz H, Herzog H, Aulich A, Feinendegen LE: PET and neuropsychology in thalamic infarction: evidence for associated cortical dysfunction. Psychiatry Res 1989; 29:363-365
41. Rafal RD, Posner MI: Deficits in human visual spatial attention following thalamic lesions. Proc Natl Acad Sci USA 1987; 84: 7349-7353
42. Buchsbaum MS, Haier RJ, Potkin SG, Nuechterlein K, Bracha S, Katz M, Lohr J, Wu J, Lottenberg S, Jerabek PA, Trenary M, Tafalla R, Reynolds C, Bunney WE: Fronto-striatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry 1992; 49:935-942
43. Mazziotta JC, Phelps ME, Plummer D, Kuhl DE: Quantitation in positron emission tomography, 5: physical-anatomical effects. J Comput Assist Tomogr 1981; 5:734-743
44. McGhie A, Chapman J: Disorders of attention and perception in early schizophrenia. Br J Med Psychol 1961; 34:101-116
45. Venables P: Input dysfunction in schizophrenia, in Progress in Experimental Personality Research. Edited by Maher A. Orlando, Fla, Academic Press, 1964, pp 1-47
46. Buchsbaum MS, Silverman J: Stimulus intensity control and the cortical evoked response. Psychosom Med 1968; 30:12-22
47. Bunney WE Jr, Bunney BG: New hypotheses in schizophrenia, in Psychiatry: A World Perspective, vol 2: Proceedings of the VIII World Congress of Psychiatry, Athens, 12-19 October 1989. Edited by Stefanis CN, Soldatos CR, Rabavilas AD. Amsterdam, Elsevier, 1990, pp 37-44